Open AccessPhase II trial of dasatinib for recurrent or metastatic c-KIT expressing adenoid cystic carcinoma and for nonadenoid cystic malignant salivary tumors
Author(s) -
Stuart J. Wong,
Karrison,
Hayes,
Kies,
; Cullen,
Tanvetya,
Argiris,
Takebe,
; Lim,
Saba Saba,
Worden,
Frédéric Gilbert,
Christof Lenz,
Razak,
Andrea Roberts,
Vokes,
Cohen
Publication year - 2016
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/kz22-gz40
Subject(s) - adenoid cystic carcinoma , dasatinib , medicine , salivary gland , pathology , oncology , carcinoma , cancer research , tyrosine kinase , receptor